1. Approach to pediatric retinal disease
Ghanbari MD
1391:12:10

2. LCA
LCA

3. Infant with normal fundus and low vision
LCA
Stationary night blindness
Achromatopsia
Immue retinopathy

9. Development of the Retina
The retina develops over a relatively long period of time beginning from the early gestational period through the first years of life.

11. Artist’s conception of the perceptual appearance of a visual scene for infants of different ages.
(a) Newborn, (b) 1 month, (c) 2 months,
(d) 3 months, (e) 6 months,
(f) adult. (copyright by Tony Young;
used with permission)

12. Electroretinographic Testing in Infants and Children
ERG can be recorded as in preterm infants

13. Retinopathy of Prematurity (ROP)
Signs and symptoms:
Retinopathy of prematurity (ROP) affects low-birth-weight premature infants and can lead to blindness; the incidence of ROP has increased, as smaller and younger babies are surviving.

14. ROP Risk factors:
Birth before 32 weeks' gestation, especially before 30 weeks
Birth weight of less than 1500 g, especially less than 1250 g
Possible risk factors include:
Supplemental oxygen,
Hypoxemia,
Hypercarbia,
Concurrent illness.

15. Treatment of ROP Cryotherapy Laser surgery Scleral buckling Vitrectomy
Anti-VEGF

16. Treatment may also be initiated for the following retinal findings:
Zone 1 ROP - Any stage, with plus disease
Zone 1 ROP - Stage 3, with no plus disease
Zone 2 ROP - Stage 2 or 3, with plus disease
Treatment should generally be accomplished, when possible, within 72 hours of determination of treatable disease to minimize the risk of retinal detachment.

17. An Updated Study of the Use of Bevacizumab in the Treatment of Patients with Prethreshold Retinopathy of Prematurity in Taiwan.

18. FAMILIAL EXUDATIVE VITREORETINOPATHY

19. )
Persistent Hyperplastic Primary Vitreous (PHPV

20. A Language for Retinoblastoma: Guidelines and Standard Operating Procedures
Retinoblastoma is the most common primary malignant intraocular tumor in children.

21. International Classification for Intraocular Retinoblastoma
Group A
Small tumors (3 mm across or less) that are confined to the retina and are not near important structures such as the optic disk (where the optic nerve enters the retina) or the foveola (the center of vision).
Group B
All other tumors (either larger than 3 mm or small but close to the optic disk or foveola) that are still confined to the retina.
Group C
Well-defined tumors with small amounts of spread under the retina (subretinal seeding) or into the gelatinous material that fills the eye (vitreous seeding).
Group D
Large or poorly defined tumors with widespread vitreous or subretinal seeding. The retina may have become detached from the back of the eye.
Group E
The tumor is very large, extends near the front of the eye, is bleeding or causing glaucoma (high pressure inside the eye), or has other features that mean there is almost no chance the eye can be saved.

22. Shields et al analyzed 249 eyes with retinoblastoma treated with intravenous chemoreduction and found that success was: achieved in of
Group A 100%,
Group B 93%,
Group C 90%,
Group D 47% eyes.
A later study identified treatment success with intra-arterial chemotherapy (IAC) in 100% of group C and D eyes, and 33% of group E eyes.

23. High-Risk Retinoblastoma Based on International Classification of Retinoblastoma: Analysis of 519 Enucleated Eyes
On the basis of the ICRB, 17% of group D and 24% of group E eyes are at increased risk for metastatic disease. In this study, 8% of patients developed metastasis. There was no metastasis in any patient classified with non–high-risk retinoblastoma.

24. ضمن عرض پوزش
بدلیل حجم بالای LECTUER ادامه اسلایدها امکان پذیر نمیباشد در صورت نیاز به ادامه لطفا به واحد سمعی و بصری مرکز آموزشی درمانی فیض مراجعه و یا با شماره تلفن داخلی 392 تماس حاصل نمائید با تشکر